Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
113.3 USD | -8.21% | -12.23% | +17.53% |
May. 28 | Sarepta Therapeutics Shares Fall After RBC Downgrade | MT |
May. 28 | RBC Downgrades Sarepta Therapeutics to Sector Perform From Outperform, Lowers Price Target to $142 From $157 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.53% | 10.71B | |
+9.83% | 115B | |
+10.80% | 105B | |
-10.84% | 22.71B | |
-1.66% | 21.83B | |
-10.67% | 18.18B | |
-41.92% | 16.52B | |
-15.11% | 16.01B | |
+6.62% | 14.14B | |
-30.73% | 7.6B |
- Stock Market
- Equities
- SRPT Stock
- News Sarepta Therapeutics, Inc.
- Sarepta Therapeutics Swings to Q4 Profit, Revenue Increases; Shares Rise After Market